InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Tempy Free
01/10/20 10:39 AM
profile icon
DTGoody Grandfathered
01/10/20 10:08 AM
profile icon
Tempy Free
01/10/20 9:20 AM
profile icon
DTGoody Grandfathered
01/10/20 8:29 AM
profile icon
Tempy Free
01/10/20 7:48 AM
profile icon
DTGoody Grandfathered
01/09/20 3:52 PM
profile icon
Tempy Free
01/08/20 2:58 PM
profile icon
DTGoody Grandfathered
01/08/20 2:43 PM
profile icon
Tempy Free
01/08/20 2:42 PM
profile icon
DTGoody Grandfathered
01/08/20 2:36 PM
profile icon
Tempy Free
01/08/20 2:28 PM
profile icon
DTGoody Grandfathered
01/08/20 12:31 PM
profile icon
DTGoody Grandfathered
01/08/20 12:23 PM
profile icon
DTGoody Grandfathered
01/07/20 2:39 PM
profile icon
NSX Free
12/20/19 8:15 AM
profile icon
Tempy Free
12/19/19 4:14 PM
profile icon
MWM Free
12/19/19 1:26 PM
profile icon
DTGoody Grandfathered
12/19/19 1:25 PM
profile icon
DTGoody Grandfathered
12/18/19 4:11 PM
profile icon
DTGoody Grandfathered
12/15/19 8:10 PM
profile icon
DTGoody Grandfathered
12/12/19 3:33 PM
profile icon
MWM Free
12/12/19 3:31 PM
profile icon
DTGoody Grandfathered
12/12/19 3:30 PM
profile icon
hyder Free
12/12/19 11:29 AM
profile icon
MWM Free
12/11/19 1:41 PM
profile icon
MWM Free
12/11/19 9:24 AM
profile icon
Couch Free
12/11/19 8:46 AM
profile icon
MWM Free
12/10/19 7:55 PM
profile icon
MWM Free
12/10/19 11:20 AM
profile icon
Couch Free
12/09/19 2:48 PM
profile icon
europtiger Free
12/09/19 9:56 AM
profile icon
NSX Free
12/09/19 9:55 AM
profile icon
Tutu Free
12/09/19 9:35 AM
profile icon
NSX Free
12/09/19 9:07 AM
profile icon
Amikik Free
12/09/19 7:22 AM
profile icon
whytestocks Free
12/04/19 1:55 PM
profile icon
ClayTrader Free
11/27/19 4:07 PM
profile icon
ClayTrader Free
11/19/19 5:03 PM
profile icon
NSX Free
11/17/19 12:54 PM
profile icon
ClayTrader Free
11/12/19 4:33 PM
profile icon
NSX Free
11/12/19 10:27 AM
profile icon
Firedog01890 Free
11/07/19 2:43 PM
profile icon
NSX Free
11/07/19 12:59 PM
profile icon
Firedog01890 Free
11/07/19 10:29 AM
profile icon
NSX Free
11/05/19 2:27 PM
profile icon
NSX Free
10/18/19 5:47 AM

ArQule Inc. (ARQL) RSS Feed

Followers
32
Posters
91
Posts (Today)
0
Posts (Total)
369
Created
07/19/06
Type
Free
Moderators

http://www.arqule.com/

http://finance.yahoo.com/q/h?s=ARQL

http://library.corporate-ir.net/library/82/829/82991/items/251342/ArQuleJune07.pdf

http://www.clinicaltrials.gov/ct/search;jsessionid=6800B95BD4EAC4F758634AECE97FE6F8?term=arqule

ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets. Its lead product ARQ 197 is an orally administered inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in microphthalmia transcription factor associated tumors, non-small cell lung cancer, pancreatic adenocarcinoma, and hepatocellular carcinoma. The company?s clinical stage products also include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. It?s preclinical and discovery programs comprise ARQ 621 focused on inhibition of the Eg5 kinesin spindle protein; ARQ 761, a second-generation E2F-1 activator; and BRAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
ARQL Latest News
  • No Recent News Available for this company!
New Post